Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-05-040925
Filing Date
2005-07-19
Accepted
2005-07-19 11:00:01
Documents
1
Period of Report
2005-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 - RESTRICTED STOCK GRANT rrd85656.html 4  
1 FORM 4 - RESTRICTED STOCK GRANT rrd85656.xml 4 3442
  Complete submission text file 0001181431-05-040925.txt   5114
Mailing Address
Business Address 321 ARSENAL STREET WATERTOWN MA 02472 6176737800
OXIGENE INC (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ASYA ALEXANDROVICH ONE FINANCIAL CENTER BOSTON MA 021111
Business Address
MURPHY JAMES B (Reporting) CIK: 0001282721 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21990 | Film No.: 05960769